Ganglioneuroblastoma
Classification according to ICD-10 | |
---|---|
C47 | Malignant neoplasm: peripheral nerves and autonomic nervous system, |
C47.1 | Peripheral nerves of the upper extremity, including the shoulder |
C47.2 | Peripheral nerves of the lower extremity, including the hip |
C47.3 | Peripheral nerves of the thorax |
C47.3 | Peripheral nerves of the abdomen |
C47.5 | Peripheral nerves of the pelvis |
C47.9 | not further described |
ICD-10 online (WHO version 2019) |
Classification according to ICD-O-3 | |
---|---|
9490/3 | Ganglioneuroblastoma |
ICD-O-3 first revision online |
The ganglioneuroblastoma (formerly also known as malignant ganglioneuroma ) is a rare tumor of the nervous system, the differentiation of which is to be classified between neuroblastoma and ganglioneuroma. Most tumors are located in the trunk, especially in the retroperitoneal space along the sympathetic ganglia on both sides of the spine or the posterior mediastinum . The tumors can often calcify.
morphology
A distinction is made between two forms: the Schwannzell-stroma-rich (imperfect) variant with all levels of neuronal differentiation, and the mixed form of Schwann-cell-stroma-rich and Schwann-cell-stroma-poor parts, or immature variant. The latter variant has a slightly poorer clinical prognosis.
Differential diagnosis
In particular, the tumor must be differentiated from the differentiating neuroblastomas.
further reading
- K. Koike, M. Iihara et al. a .: Adult-type ganglioneuroblastoma in the adrenal gland treated by a laparoscopic resection: report of a case. In: Surgery today. Volume 33, Number 10, 2003, pp. 785-790, ISSN 0941-1291 . doi : 10.1007 / s00595-003-2565-8 . PMID 14513331 . (Review).
- GJ Lonergan, CM Schwab u. a .: Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. In: Radiographics. Volume 22, Number 4, 2002 Jul-Aug, pp. 911-934, ISSN 0271-5333 . PMID 12110723 . (Review).
Individual evidence
- ↑ C. Aoyama, SJ Qualman et al. a .: Histopathologic features of composite ganglioneuroblastoma. Immunohistochemical distinction of the stromal component is related to prognosis. In: Cancer . Volume 65, Number 2, January 1990, pp. 255-264, ISSN 0008-543X . PMID 2295048 .